chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shot is very powerful, if you get shingles you'll be way worst with the pain it causes; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient's doctor recently gave him/her the shingle vaccine, that shot was very powerful, but the patient heard if anyone get shingles, he/she would be way worst with the pain it causes. The follow-up would not possible as no contact details were available.
Administered 7-19-18. 7 PM 7-19-18 Fatigue, malaise, all over body aching and warmth. Rt. arm (deltoid) aching, no swelling, no redness. 8 AM 7-20-18 Upon waking hives x 6 splotchy over R. upper arm.
woke one Am-rt hand felt stiff-painful-painful to exert force-next day better-noticed sx again in 1wk;sx lasted all day;took ASA w/relief next day;sx recurred w/gardening-pain relieved w/ASA;
Initial unsolicited report received from a consumer (patient herself) on 12-Dec-2017. This case involves a 68-year-old female patient who was vaccinated with 0.5 ml single dose of FLUZONE HD (Batch number: UI885AA, expiry date, dose in series and site of administration were not reported) via intramuscular route on 07-Dec-2017 (also reported as Thursday). Patient medical conditions includes diabetes type 2 and hypertension and she was allergic to erythromycin, DILAUDID, lisinopril and sensitivity to latex. Concomitant medications were not reported. On an unknown date (reported as by Saturday), following the vaccination, the patient woke up with dizziness and vertigo but these symptoms passed after she drank fluids. On an unknown date (also reported as Sunday), she again woke up with dizziness and vertigo. She stated her head was spinning all day and went to the emergency room (ER), Urine test, blood test and Computerized Tomography (CT scan) were done, results were within normal limit and blood pressure (BP) was 187/110. She was given MECLIZINE in the ER and discharged home. The patient stated that symptoms had improved some, but she felt a spacey sensation in her head and when she first got up she was wobbly on her feet. Other laboratory investigations and other corrective treatment were not reported. On an unknown date, the patient was recovered from dizziness and head spinning (reported as no further dizziness or vertigo) and was recovering from blood pressure increased. List of documents held by sender: none.
After the first vaccine I had all the symptoms. I ended up getting a UTI and sinus infection. I called the doctor's office for these symptoms. They did 2 Covid tests, I was positive for the PCR. It was almost 2 weeks since I had the vaccine. For the second dose I had a roaring sinus infection again. I called the doctor last Wednesday. They gave me Amoxycillin and oral steroids.
I was sick as a dog; feel bad; Initial information was received on 01-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient (unknown demographics) who was sick (illness) as a dog and feel bad (feeling abnormal), while received INFLUENZA VACCINE.  Medical history, past medical treatment, vaccination, family history and concomitant medications were not provided.  On an unknown date, the patient received an INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, patient was sick (illness) as a dog and feel bad (feeling abnormal), (unknown latency), following the administration of INFLUENZA VACCINE.   Details of laboratory data not reported.  Corrective treatment and outcome were unknown at the time of reporting.  There will be no information available on the batch number for this case.
PRESENTED THIS AM WITH FEVER ,BODY ACHES ,RASH   MOM ASSUMeD BUG BITE. NOTED SMALL BLISTERS DA  CHICKEN POX BY PROVIDER . MOM PHONED ON 7/7/2005 STATING >50 POX
This spontaneous report was received from a certified medical assistant refers to a multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown dates, the patients were vaccinated with an improperly stored doses of GARDASIL, lot number K026246, expiration date 28-JAN-2017, (dose and route were not reported). There was no concomitant medication reported. No adverse effect was reported. No product quality complaint was involved. It was unknown if the patients sought medical attention. This is one of several reports from the same source. Additional information has been requested.
one week later I was sick; got a flu shot; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 26-Nov-2020.  This case involves a patient of unknown demographics who experienced got a flu shot (influenza) and one week later patient was sick (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got a flu shot (influenza) and one week later patient was sick (illness), (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
On 1/19/21- visual migraine, severe fatigue, difficulty concentrating. These symptoms continued along with blurry vision, dizziness, waking at night to ?buzzing? in head, hypoglycemic symptoms. Multiple doctors visits over the past two months, blood tests, BP and heart rate assessments - only to assume it?s  a reaction to the vaccine. Extreme diet change, elimination of the two prescribed meds and detox- feeling much better however still experiencing hypoglycemic symptoms throughout the day and sometimes at night.
I had Nausea, Vomiting, and Abdominal pain starting after days after receiving the first shot. I went to a urgent care and received a shot for nausea/vomiting and had an exray of my abdomen. A few days after receiving my second shot I went to the ER and was diagnosed with Necrotising Pancreatitis. This happened between 4/10/2021 and 5/12/2021
Red rash on upper body and thighs, arms, and neck.  I first noticed itchy bumps on my left wrist on Thursday, 4/15/2021 where my long-sleeved shirt cuff was rubbing.  Slightly itchy rash on sides and back, and especially on neck where my collar rubs.  I didn't notice rash on neck until Saturday, 4/17/2021 about 1:00 PM.  On Friday 4/16 I applied 1% hydrocortisone cream to my wrist and it alleviated the itch, but the rash is still there, on both arms.
Cluster of 7 adult patients (no individual patient identification provided) developed cellulitis after receiving DAPTACEL (lot number unknown) in error, received from a pharmacist on 14 May 2007.  No further information was provided.
pt passed out at the parking lot and then become conscious. he said that he was feeling chill and hot.  called pt on 9/28  and he said he is feeling better and there was no explanation why he passed out.
Pharmacist administered dose of Moderna after the 6 hour punctured expiration time.  This vial was left over from the previous day she administered doses and she used the same vial the next calendar day to do the first 8 doses for the day.    Pt is being offered 2nd dose again, will schedule asap if pt agrees
This spontaneous report was received from a registered nurse concerning to a 47 years old female patient with asthma, anxiety, codeine allergy and doxycycline allergy. On 04-SEP-2012, the patient was vaccinated intramuscularly in the gluteus maximus, left side with lot # (672673/0492AE; expiration date 22-AUG-2013), first dose of, 0.5 ml PNEUMOVAX23. No other co-suspects were reported. Concomitant medications included influenza virus vaccine (GSK), fluticasone propionate, ADVAIR, XANAX, albuterol (manufacturer unspecified), albuterol sulfate, DUONEB, NEXIUM and ibuprofen. The nurse reported that the patient developed a cellulitis that required hospitalization following vaccination with PNEUMOVAX23. The patient had flu like symptoms, nausea, elevated temperature (unspecified) and a swollen, tender and painful area described as a cellulitis at the injection site of the PNEUMOVAX23 with rigors and limp. The exact development of the flu like symptoms, nausea, elevated temperatures (unspecified) and a swollen, tender and painful area described as a cellulitis at the injection of the PNEUMOVAX23 with rigors and limp was unspecified. The patient went to the office on 06-SEP-2012 and then went to the emergency room and was admitted to the hospital on 06-SEP-2012 for treatment of the cellulitis. The patient was discharged from the hospital on 09-SEP-2012, but went back to the physician office and emergency room on 11-SEP-2012 with symptoms of nausea, increased swelling, pain and tenderness at the injection site. The patient was given a computed tomography (CT) scan of the pelvis and abdomen on 11-SEP-2012 which indicated inflammation, but no abscesses or hematoma. The patient was sent to home after treatment with ZOFRAN, intravenous (IV) fluids generic (KEFLEX) and PERCOCET on 11-SEP-2012. The patient was reported to be recovered on 24-SEP-2012. The patient missed work (unspecified number of days) and could not walk right, limped. The relatedness for the events were unknown for PNEUMOVAX23. This is one report of several reports from the same source. Cellulitis, missed work and could not walk right, limped were considered to be life threatening by the registered nurse. Cellulitis was considered to be disabling by the registered nurse. Additional information has been requested.
Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 87 and had a hospital stay from 2/18/21-2/24/21 for an NSTEMI and 2 broken ribs from 3 falls in the prior week. After hospitalization he was bedridden, disoriented and hallucinating. Comorbidities include CAD, CHF, HTN, and carotid artery stenosis.
Information has been received from an immunization technician. She heard from a patient who heard from an occupational therapist who heard from another person that one patient with a history of seizure was vaccinated with the second dose of GARDASIL. Concomitant therapy included seizure medication. Subsequently the patient experienced seizure. It was unknown if the patient was hospitalized. It was reported that "the patient was diagnosed with epilepsy". Therapy with GARDASIL was discontinued. At the time of reporting, the outcome was unknown. It is unknown if the patient sought medical attention. Upon internal review, epilepsy was determined to be an other important medical event. This is one of several reports received from the same source. The Immunization Technician stated that she did not remember the patient's name or contact information who reported that she heard about a patient that was diagnosed with epilepsy after receiving GARDASIL. Attempts to verify the existence of an identifiable patient have been unsuccessful. Additional information is not expected.
bad reaction to the shot; bright red rash all over his chest and back; sweat; chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (bad reaction to the shot), RASH ERYTHEMATOUS (bright red rash all over his chest and back), HYPERHIDROSIS (sweat), CHILLS (chills) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (bad reaction to the shot), RASH ERYTHEMATOUS (bright red rash all over his chest and back), HYPERHIDROSIS (sweat), CHILLS (chills) and PYREXIA (Fever). At the time of the report, VACCINATION COMPLICATION (bad reaction to the shot), RASH ERYTHEMATOUS (bright red rash all over his chest and back), HYPERHIDROSIS (sweat), CHILLS (chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment medications were unknown.
No additional AE; PEDVAXHIB was administered post temperature excursion; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not provided.  On 23-NOV-2020, the patient was vaccinated with an improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, dose, vaccination scheme frequency, route of administration, and anatomical site of vaccination were not reported; lot number T001207, which have been verified to be valid, expiration date reported and validated as 09-JUN-2022) as prophylaxis (product storage error).   The administered dose of the vaccine experienced a temperature excursion of 9.2 degrees Celsius (C) for 9 minutes. There was no previous temperature excursion reported and no digital data logger was not involved. No adverse events were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2012USA000913: US-009507513-2012USA000834: US-009507513-2012USA001255: US-009507513-2012USA000997: US-009507513-2012USA001384:
Normal labor and delivery on 12/12/2021. Hospital admission within 6 weeks of receiving the COVID vaccine.
2 DAYS AFTER DOSE PATIENT HAD DROOPING FOREHEAD, HEAVY ON THE EYES PER DAUGHTER
mild left arm soreness; mild left arm redness; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (mild left arm soreness) and VACCINATION SITE ERYTHEMA (mild left arm redness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 030L20AH) for COVID-19 prophylaxis.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (mild left arm soreness) and VACCINATION SITE ERYTHEMA (mild left arm redness). At the time of the report, VACCINATION SITE PAIN (mild left arm soreness) and VACCINATION SITE ERYTHEMA (mild left arm redness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was reported by a physician (patient's husband).  Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2022-660549, MOD-2022-660557, MOD-2022-660560, MOD-2022-660563 (Patient Link).
I don't know if this is an adverse event, but I wanted to report symptoms I'm experiencing.  2 days after receiving the second injection for the Pfizer COVID-19 vaccine, I noticed a tender lump above my collarbone on the left side; the lump was not immediately visible, but I could feel it with my fingers and move it around.  After examining the site of the lump, it appeared to be swollen when compared to my collarbone on the right side.  The lump on the left side is the same side I received the injection.  After researching, it appears that the tender lump may be a swollen lymph node(s) near my collar bone related to the Pfizer vaccine.  It has now been present for 5 days, but appears to be reducing in size and sensitivity as time goes on.  I have contacted my primary care provider who has instructed me to monitor the lump and follow up in person after a few weeks if it has not subsided.
went into AFIB 3/6/21 ....ER and inpatient from 3/6 to 3/9   No previous heart events whatsoever  Hospital cardiac nurse said she had recently been made aware of several cases of Pfizer shot leading to AFIB....said she was on a committee
Patient requested a Pfizer bivalent COVID booster but received a monovalent Pfizer COVID booster instead. The patient was informed about the event and was told that based on recommendations on website another shot was not needed at this time but if they would like the bivalent they would be eligible in 2 months.
being sick; chills; feeling really bad fatigue; I can't sit for more than 15 minutes"; lifting arm is challenging; arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (I can't sit for more than 15 minutes"), MALAISE (being sick), VACCINATION SITE PAIN (arm is sore), CHILLS (chills) and FATIGUE (feeling really bad fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm is sore) and LIMB DISCOMFORT (lifting arm is challenging). On 25-Mar-2021, the patient experienced MOVEMENT DISORDER (I can't sit for more than 15 minutes"), CHILLS (chills) and FATIGUE (feeling really bad fatigue). On an unknown date, the patient experienced MALAISE (being sick). At the time of the report, MOVEMENT DISORDER (I can't sit for more than 15 minutes"), MALAISE (being sick), VACCINATION SITE PAIN (arm is sore), CHILLS (chills), FATIGUE (feeling really bad fatigue) and LIMB DISCOMFORT (lifting arm is challenging) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported  No treatment information was provided
Developed ataxia day 7 after MMR. Seen in office on day 8 and referred to ER. Was seen by neurologist next day.
DAY2:  POST SHOT PATIENT DEVELOPED 104 FEVER AND HAD SYNCOPAL EPISODE,  DAY3:  DEVELOPED VESICULAR SORES IN NOSE DAY4:  EXTREME ARM PAIN AND PAIN TO RIGHT SIDE OF CHEST WITH DEEP INSPIRATION AND COUGH DAY5: RIGHT SHARP EAR PAIN ALL DAYS EXTREME NAUSA AND GENERALIZED WEAKNESS, SEEN IN CLINIC ON DAY 7 POST SHOT
The day after receiving Shingrix, patient had swelling, itch, hot to touch and pain around the area of the vaccine.  Third day after the vaccine, the selling went down after applying ice.  On the 6th day, Nov 27, patient came to the pharmacy and asked me question about her vaccine.  She stated that it was still red and still a small amount of pain.
had diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "swelling on my leg" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: ASPIRIN (E.C.) taken for peripheral swelling; ESPERAL taken for peripheral swelling; CALCIUM; and other routine medicine for blood pressure and cholesterol. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "had diarrhea". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of diarrhoea with Alka Seltzer, Tums and Imodium.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300222264 same patient/suspect product; different dose and events;US-PFIZER INC-202300222255 same patient/suspect product; different dose and events;
Vomiting, headache, fever of 102'.  Lasted for 24 hrs.
The day after injection number 2 I developed a very itchy rash on my right hand and forearm.  This has continued and traveled all over my body since that time.  About 8 weeks ago it intensified and I was treated by a dermatologist with several different ointments which did not work and they also took a biopsy of the rash. Two weeks ago I went to an allergist who indicated it appeared to be an immune response to the vaccine.  I just finished a 10 day course of prednisone and continue on fexofenadine 180 mg and famotidine 20mg both twice daily.  In addition I have been using a compounded creme with topical steroid, anti itch cream and a moisturizer twice per day.  The rash is improving however my concern is now that I completed the prednisone (yesterday) it will ramp up again.  I continue to have areas of the rash which are quite itchy.  If itched sores develop. In addition to the rash I also had an outbreak of cold sores in my nose - about 10 of them.  They lasted about the typical length of time for a cold sore.  This also occurred the day after the second injection.
Mom brought pt to ER c/o being cranky & crying & vomiting; on exam was alert, playful, t99.3 (R); dx rxn to DTP; rx-Pedicare decongestant drops x 5 days;
Patient started getting itchy the night after the vaccination. Patient also  had fever, body aches and chills. The following day the patient developed a rash all over his body.
Client became nauseous and vomited about 5 minutes after all vaccines administered. Only 1 vomiting episode and nausea lasted about 10 minutes. Client vital signs were taken and client remained seated in a chair. All vital signs were stable and client verbalized feeling ok and back to normal about 10 minutes after incident began.
Vaccination discoloration - site. Vaccination inflammation - site. Muscle aches. Fever. Has had shingles 5/2012 on right side.
After 20 minutes of receiving the vaccine, the patient complained of a headache and feeling disoriented. He was slightly dizzy, but the main complaint was a bad headache and being disoriented.
2 hours later, periorbital and labial angioedema, lasted 4 days.
Localized reaction. Redness, swelling, and itching to injection site. symptoms started 6 days post vaccination and localized to injection site. Treatment ice, hydrocortisone cream, and Claritin.
FELT HOT AND FAINTED, UNCONSCIOUS X 5 SECS THEN WOKE UP. CODE GREEN CALLED, AOX3, REFUSED TRANSPORT, AMA SIGNED.